In addition, RHOAG17V and TET2 mutations coexist frequently in AITL patients with IDH2 mutations, suggesting that multiple mutations may work together to drive the transformation of this cell type (43). This evidence concerns the gene IDH2 and angioimmunoblastic T-cell lymphoma.